US Stock MarketDetailed Quotes

Xenetic Biosciences (XBIO)

Watchlist
  • 3.044
  • -0.066-2.12%
Close May 15 16:00 ET
  • 3.044
  • 0.0000.00%
Post 20:01 ET
6.97MMarket Cap-2.56P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xenetic Biosciences (XBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
19.04%2.98M
18.11%766.3K
67.19%1.03M
-18.79%589.9K
16.14%593.26K
-1.56%2.5M
-3.44%648.82K
0.50%614.24K
11.58%726.4K
-15.69%510.82K
Operating revenue
19.04%2.98M
18.11%766.3K
67.19%1.03M
-18.79%589.9K
16.14%593.26K
-1.56%2.5M
-3.44%648.82K
0.50%614.24K
11.58%726.4K
-15.69%510.82K
Cost of revenue
Gross profit
Operating expense
-13.33%5.81M
-20.52%1.39M
41.12%1.57M
-36.32%1.31M
-13.69%1.54M
-4.97%6.7M
-9.32%1.75M
-36.64%1.11M
11.61%2.06M
16.98%1.78M
Selling and administrative expenses
-19.64%2.75M
-12.73%615.91K
9.32%815.21K
-41.79%657.75K
-21.35%656.64K
-4.06%3.42M
-25.87%705.71K
1.15%745.73K
19.46%1.13M
-9.81%834.91K
-General and administrative expense
-19.64%2.75M
-12.73%615.91K
9.32%815.21K
-41.79%657.75K
-21.35%656.64K
-4.06%3.42M
-25.87%705.71K
1.15%745.73K
19.46%1.13M
-9.81%834.91K
Research and development costs
-6.78%3.07M
-25.79%773.42K
105.57%756.48K
-29.69%656.56K
-6.91%879.03K
-5.91%3.29M
6.83%1.04M
-63.94%367.99K
3.38%933.77K
58.64%944.32K
Operating profit
32.58%-2.83M
43.32%-623.03K
-9.06%-544.73K
45.83%-724.41K
25.70%-942.41K
6.89%-4.2M
12.47%-1.1M
56.44%-499.47K
-11.62%-1.34M
-38.60%-1.27M
Net non-operating interest income expense
-40.77%148K
-15.57%43.79K
-49.78%30.78K
-46.05%34.23K
-46.50%39.19K
-29.77%249.86K
-38.07%51.87K
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
Non-operating interest income
-40.77%148K
-15.57%43.79K
-49.78%30.78K
-46.05%34.23K
-46.50%39.19K
-29.77%249.86K
-38.07%51.87K
-33.22%61.3K
-49.69%63.45K
35.39%73.25K
Other net income (expense)
200.30%5.73K
102.20%159
166.69%4.01K
7,133.33%1.48K
50.00%78
-122.49%-5.71K
-1,892.82%-7.24K
325.83%1.5K
-100.10%-21
-98.85%52
Other non- operating income (expenses)
200.30%5.73K
102.20%159
166.69%4.01K
7,133.33%1.48K
50.00%78
-122.49%-5.71K
-1,892.82%-7.24K
325.83%1.5K
-100.10%-21
-98.85%52
Income before tax
32.31%-2.68M
45.09%-579.08K
-16.78%-509.94K
45.94%-688.7K
24.43%-903.14K
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
Income tax
Net income
32.31%-2.68M
45.09%-579.08K
-16.78%-509.94K
45.94%-688.7K
24.43%-903.14K
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
Net income continuous Operations
32.31%-2.68M
45.09%-579.08K
-16.78%-509.94K
45.94%-688.7K
24.43%-903.14K
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
Minority interest income
Net income attributable to the parent company
32.31%-2.68M
45.09%-579.08K
-16.78%-509.94K
45.94%-688.7K
24.43%-903.14K
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
32.31%-2.68M
45.09%-579.08K
-16.78%-509.94K
45.94%-688.7K
24.43%-903.14K
4.22%-3.96M
9.99%-1.05M
58.63%-436.67K
-21.22%-1.27M
-39.53%-1.2M
Basic earnings per share
38.52%-1.58
67.65%-0.22
-17.86%-0.33
45.78%-0.45
24.36%-0.59
5.17%-2.57
11.69%-0.68
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
Diluted earnings per share
38.52%-1.58
67.65%-0.22
-17.86%-0.33
45.78%-0.45
24.36%-0.59
5.17%-2.57
11.69%-0.68
59.42%-0.28
-20.29%-0.83
-39.29%-0.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 19.04%2.98M18.11%766.3K67.19%1.03M-18.79%589.9K16.14%593.26K-1.56%2.5M-3.44%648.82K0.50%614.24K11.58%726.4K-15.69%510.82K
Operating revenue 19.04%2.98M18.11%766.3K67.19%1.03M-18.79%589.9K16.14%593.26K-1.56%2.5M-3.44%648.82K0.50%614.24K11.58%726.4K-15.69%510.82K
Cost of revenue
Gross profit
Operating expense -13.33%5.81M-20.52%1.39M41.12%1.57M-36.32%1.31M-13.69%1.54M-4.97%6.7M-9.32%1.75M-36.64%1.11M11.61%2.06M16.98%1.78M
Selling and administrative expenses -19.64%2.75M-12.73%615.91K9.32%815.21K-41.79%657.75K-21.35%656.64K-4.06%3.42M-25.87%705.71K1.15%745.73K19.46%1.13M-9.81%834.91K
-General and administrative expense -19.64%2.75M-12.73%615.91K9.32%815.21K-41.79%657.75K-21.35%656.64K-4.06%3.42M-25.87%705.71K1.15%745.73K19.46%1.13M-9.81%834.91K
Research and development costs -6.78%3.07M-25.79%773.42K105.57%756.48K-29.69%656.56K-6.91%879.03K-5.91%3.29M6.83%1.04M-63.94%367.99K3.38%933.77K58.64%944.32K
Operating profit 32.58%-2.83M43.32%-623.03K-9.06%-544.73K45.83%-724.41K25.70%-942.41K6.89%-4.2M12.47%-1.1M56.44%-499.47K-11.62%-1.34M-38.60%-1.27M
Net non-operating interest income expense -40.77%148K-15.57%43.79K-49.78%30.78K-46.05%34.23K-46.50%39.19K-29.77%249.86K-38.07%51.87K-33.22%61.3K-49.69%63.45K35.39%73.25K
Non-operating interest income -40.77%148K-15.57%43.79K-49.78%30.78K-46.05%34.23K-46.50%39.19K-29.77%249.86K-38.07%51.87K-33.22%61.3K-49.69%63.45K35.39%73.25K
Other net income (expense) 200.30%5.73K102.20%159166.69%4.01K7,133.33%1.48K50.00%78-122.49%-5.71K-1,892.82%-7.24K325.83%1.5K-100.10%-21-98.85%52
Other non- operating income (expenses) 200.30%5.73K102.20%159166.69%4.01K7,133.33%1.48K50.00%78-122.49%-5.71K-1,892.82%-7.24K325.83%1.5K-100.10%-21-98.85%52
Income before tax 32.31%-2.68M45.09%-579.08K-16.78%-509.94K45.94%-688.7K24.43%-903.14K4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M
Income tax
Net income 32.31%-2.68M45.09%-579.08K-16.78%-509.94K45.94%-688.7K24.43%-903.14K4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M
Net income continuous Operations 32.31%-2.68M45.09%-579.08K-16.78%-509.94K45.94%-688.7K24.43%-903.14K4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M
Minority interest income
Net income attributable to the parent company 32.31%-2.68M45.09%-579.08K-16.78%-509.94K45.94%-688.7K24.43%-903.14K4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 32.31%-2.68M45.09%-579.08K-16.78%-509.94K45.94%-688.7K24.43%-903.14K4.22%-3.96M9.99%-1.05M58.63%-436.67K-21.22%-1.27M-39.53%-1.2M
Basic earnings per share 38.52%-1.5867.65%-0.22-17.86%-0.3345.78%-0.4524.36%-0.595.17%-2.5711.69%-0.6859.42%-0.28-20.29%-0.83-39.29%-0.78
Diluted earnings per share 38.52%-1.5867.65%-0.22-17.86%-0.3345.78%-0.4524.36%-0.595.17%-2.5711.69%-0.6859.42%-0.28-20.29%-0.83-39.29%-0.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -